Anonymous wrote:

Anonymous wrote:

Anonymous wrote:

Anonymous wrote:

Anonymous wrote:

Anonymous wrote:The other thing that's stunning is the cost of medication in the USA. I know people who go on trips abroad just to stock up on their regular medicines that are 1/20 of the price in other countries.

If the cost of medication was the same globally only the us could afford it

You know that companies are often paid NOT to bring new pharmaceutical products to market, so that there’s no competition that would bring costs down? Learn about pay-not-to-play and patent abuses. It’s appalling.

It is, to be clear, perfectly logical in a system where the entire purpose of medicine is to maximize shareholder growth. But it is appalling.

Provide links and sources and not just a headline you saw.

Funny that you assume I just saw a random headline.

https://www.ftc.gov/news-events/topics/competition-enforcement/pay-delay

That’s just the beginning of the problem with the parent system. See also secondary parents and evergreening, as well as private equity buying up multiple companies in the sane therapeutic space and then holding back products to stifle competition.

Want links for those, too? Here you are:

https://anderson-review.ucla.edu/52-6-billion-extra-cost-to-consumers-of-add-on-drug-patents/

https://www.sciencedirect.com/science/article/abs/pii/S0304405X22002483

That’s probably enough to get you started. Good luck